Teva Pharmaceutical is a leader in generic drugs, but these struggling makers of branded drugs may be a better choice.

Nvidia, Alphabet, and TSMC are all tech leaders you can buy right now heading into 2026. You don't need a lot of money to ...

As you can see, Alphabet's 64% return trounced the rest of the Magnificent Seven, beating 2025's second-best performer, ...

The robotics business is at a turning point, finally integrating artificial intelligence's full potential into moving ...

Through roughly the first six months of the year, XRP 's ( XRP 1.52%) price had risen by 73%. Unfortunately, the latter half ...

However, as we enter 2026, the next big AI supercycle may be emerging. The first phase was largely about generative AI. This ...

Meanwhile, the stock is cheap, trading at a forward enterprise value (EV) -to- EBITDA of just 7.6 times 2026 analyst ...

Dividend stocks look poised to rebound in 2026, and the ones focused on balance sheet quality and long-term dividend growth ...

At that scale, identically sized inflows would struggle to make Bitcoin's price move even a little, but could move Cardano's ...

The technology sector offers explosive long-term growth potential. Here's one strong piece of evidence for that claim: Over ...

The massive, multiyear AI infrastructure buildout has created a powerful investment opportunity for long-term investors.

Steady investments into a good exchange-traded fund (ETF) can put building wealth on autopilot, a direct route to financial ...